Muro 128 Solution
Pricing Report NDC 24208-277-30

Latest NADAC: $0.71880 per ML · Effective May 23, 2018

Current Package Pricing Information

The latest wholesale acquisition cost for Muro 128 (NDC 24208-277-30) is $0.71880 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 23, 2018.

As a a human over the counter drug provided by Bausch & Lomb Incorporated, this medication is distributed in a 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.71880
Per ML

Effective Date
May 23, 2018
Data Status
As of May 15, 2019
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.61875 to $1.13010 per ML. Over this 12 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.6188 - $1.1301
Market Volatility
82.64% Variance
Latest Trend
0.12%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $1.11626 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2026 $1.11755 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2026 $1.11755 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
May 20, 2026 $1.11755 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Mar 18, 2026 $1.11783 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2026 $1.11783 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 21, 2026 $1.11689 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jan 21, 2026 $1.11689 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Dec 17, 2025 $1.11836 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 19, 2025 $1.11840 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Oct 22, 2025 $1.11856 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Sep 17, 2025 $1.11844 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026